Annual Conference

2024 NCCN Annual Conference Call for Abstracts

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, November 1, 2023, 11:59 PM ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2023. For more details on the abstract submission process and poster specifications, please see the Poster Session FAQs.


Submit Abstract


Save the dates!
NCCN 2024 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, April 5, 2024 – Sunday, April 7, 2024

This activity is supported by educational grants from:

  • Astellas and Seagen
  • AstraZeneca
  • AVEO Pharmaceuticals, Inc. (“AVEO Oncology”)
  • BeiGene
  • Coherus BioSciences
  • Eisai
  • Exact Sciences
  • Fresenius Kabi USA, LLC
  • Genentech, a member of the Roche Group
  • GSK
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Lantheus
  • Lilly
  • Novartis
  • Olympus Corporation of the Americas
  • Puma Biotechnology
  • TerSera Therapeutics LLC.


This activity is supported by independent educational grants from:

  • AbbVie
  • Daiichi Sankyo
  • Gilead Sciences, Inc.
  • Incyte Corporation

This activity is supported by medical education grants from:

  • Exelixis, Inc.
  • Karyopharm Therapeutics

This project has been made possible in part by a grant from:

  • Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from:

  • GE HealthCare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by:

  • Amgen

This activity is supported through an independent medical education grant from:

  • Merck & Co., Inc.

Supported by a grant from:

  • Pfizer Inc.



Exhibit Hall

The NCCN Exhibition Hall was held in-person and virtually for networking opportunities and to gather the latest information from industry-sponsored exhibits and more.

View Exhibit Guide


For exhibitor opportunities, contact Jennifer Tredwell, Vice President, NCCN Marketing and Communications.

2023 Annual Conference Recorded Presentations 

Experts from leading cancer centers came together to discuss updates to NCCN Guidelines®, the latest advances across several cancer types, and emerging issues in oncology.

CE credit is available for the oncology team. There are more than 30 recorded educational sessions!

Record presentations from the 2023 NCCN Annual Conference are now available on NCCN Continuing Education Portal.

Watch Now

Related Program

The NCCN 2023 Nursing Program: Advancing Oncology Nursing™ and the NCCN 2023 Oncology Fellows Program: New Horizons in Quality Cancer Care™ were held Thursday, March 30 in Orlando, FL, and virtually.

Recorded presentations from the NCCN 2023 Nursing Program: Advancing Oncology Nursing™ and the NCCN 2023 Oncology Fellows Program: New Horizons in Quality Cancer Care™are now available on NCCN Continuing Education Portal.

View the Nursing Endurings


View the Fellows Endurings